Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Incidence, prevalence, and survival of lung cancer in the United Kingdom from 2000-2021: a population-based cohort study

Corby G. et al, (2024)

Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL

Koenig F. et al, (2024), Eclinicalmedicine, 67

Electronic health records (EHRs) in clinical research and platform trials: Application of the innovative EHR-based methods developed by EU-PEARL.

Lombardo G. et al, (2023), J biomed inform, 148

Incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000-2021: a population-based cohort study

Barclay NL. et al, (2023)

Evaluating the comparability of osteoporosis treatments using propensity score and negative control outcome methods in UK and Denmark electronic health record databases

Rathod-Mistry T. et al, (2023)

Drug utilization analysis of osteoporosis medications in seven European electronic health databases.

Tan EH. et al, (2023), Osteoporos int, 34, 1771 - 1781

The impact of the COVID-19 pandemic on short-term cancer survival in the United Kingdom: a cohort analysis

Barclay NL. et al, (2023)

Risk of adverse events following the initiation of antihypertensives in older people with complex health needs: a self-controlled case series in the United Kingdom.

Jödicke AM. et al, (2023), Age ageing, 52

Safety Outcomes of Selective Serotonin Reuptake Inhibitors in Adolescent Attention-Deficit/Hyperactivity Disorder with Comorbid Depression: The ASSURE Study - CORRIGENDUM.

Kim C. et al, (2023), Psychol med

Evaluating the Comparative Effectiveness and Safety of Repurposed Drugs for COVID-19

Tan EH. et al, (2022)

Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy.

Tan EH. et al, (2022), J health psychol, 27, 1111 - 1124

Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS.

Kostka K. et al, (2022), Clin epidemiol, 14, 369 - 384

THE IMPACT OF COVID-19 ON POPULATION-LEVEL DRUG UTILIZATION OF ALENDRONATE

Tan EH. et al, (2021), Osteoporosis international, 32, S314 - S315

TREATMENT PATTERNS FOR OSTEOPOROSIS MEDICATIONS IN FIVE EUROPEAN COUNTRIES: A MULTINATIONAL REAL WORLD COHORT ANALYSIS

Robinson DE. et al, (2021), Osteoporosis international, 32, S315 - S315

COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries.

Tan EH. et al, (2021), Rheumatology (oxford), 60, SI37 - SI50

Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain.

Roel E. et al, (2021), Cancer epidemiol biomarkers prev, 30, 1884 - 1894

Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience.

Duarte-Salles T. et al, (2021), Pediatrics, 148

Abstracts of the 37th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Virtual, August 23, 2021.

(2021), Pharmacoepidemiol drug saf, 30 Suppl 1, 3 - 439

Facilitators and barriers to medication adherence with adjuvant endocrine therapy in women with breast cancer: a structural equation modelling approach.

Tan EH. et al, (2021), Breast cancer res treat, 188, 779 - 788

THE IMPACT OF COVID-19 ON POPULATION-LEVEL DRUG UTILIZATION OF ALENDRONATE

Tan EH. et al, (2021)

Load More

Include forthcoming?